Showing results (21-30 of 114) with videos related to
Sort By:
Pageof 12
Early Intervention in Psychiatry|March 10, 2026
Expanding Coordinated Specialty Care to Early-Stage Bipolar Disorder: Development and Implementation of the STRIDE ModelKathleen Miley, Carissa Coudray, David Bond, et al.Journal of Geriatric Oncology|August 29, 2020
Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignanciesJordon L Jaggers, Smith Giri, Heidi D Klepin, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2019
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationHassan Issa, Nidhi Sharma, Qiuhong Zhao, et al.Anesthesia and Analgesia|January 20, 2009
A randomized, double-blind, controlled trial of perioperative administration of gabapentin, meloxicam and their combination for spontaneous and movement-evoked pain after ambulatory laparoscopic cholecystectomyIan Gilron, Elizabeth Orr, Dongsheng Tu, et al.Transplantation and Cellular Therapy|September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center ExperienceKuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.Transplantation and Cellular Therapy|June 28, 2023
Cell Therapy Informatics: Updates on the Integration of HCT/IEC Functionalities into an Electronic Medical Record System in the US to Promote Efficiency, Patient Safety, Research, and Data InteroperabilityVincent T Ho, Thomas R Klumpp, Wayne H Liang, et al.Leukemia & Lymphoma|August 29, 2014
Lower dose of antithymocyte globulin does not increase graft-versus-host disease in patients undergoing reduced-intensity conditioning allogeneic hematopoietic stem cell transplantGalena Salem, Amy S Ruppert, Patrick Elder, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2017
Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular LymphomaNarendranath Epperla, Kwang Woo Ahn, Philippe Armand, et al.American Journal of Clinical and Experimental Urology|November 1, 2014
Metastasis as a therapeutic target in prostate cancer: a conceptual frameworkKonstantin Stoletov, David Bond, Katie Hebron, et al.Blood Advances|April 12, 2024
Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphomaNathan Denlinger, No-Joon Song, Xiaoli Zhang, et al.Pageof 12